Chuck Royce's CRL Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 84,361 shares of Charles River Laboratories International, Inc. (CRL) worth $13.2 M, representing 0.13% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Chuck Royce has maintained this position in CRL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 81,500 shares. Largest reduction occurred in Q1 2025, reducing 11,452 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Chuck Royce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +13,975 | New Buy | 13,975 | $236.40 |
| Q1 2024 | +1,617 | Add 11.57% | 15,592 | $270.95 |
| Q2 2024 | -15,592 | Sold Out | 15,592 | $0.00 |
| Q1 2025 | +4,140 | New Buy | 4,140 | $150.52 |
| Q2 2025 | +81,500 | Add 1968.60% | 85,640 | $151.73 |
| Q3 2025 | -1,279 | Reduce 1.49% | 84,361 | $156.46 |
Chuck Royce's Charles River Laboratories International Investment FAQs
Chuck Royce first purchased Charles River Laboratories International, Inc. (CRL) in Q4 2023, acquiring 13,975 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Charles River Laboratories International, Inc. (CRL) for 8 quarters since Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q2 2025, adding 85,640 shares worth $12.99 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 84,361 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $13.2 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.13% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's peak holding in Charles River Laboratories International, Inc. (CRL) was 85,640 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.